Literature DB >> 19119939

Does the implementation of an interferon-gamma release assay in lieu of a tuberculin skin test increase acceptance of preventive therapy for latent tuberculosis among healthcare workers?

Rajiv Sahni1, Cyndee Miranda, Belinda Yen-Lieberman, J Walton Tomford, Paul Terpeluk, Pearl Quartey, Lucileia T Johnson, Steven M Gordon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19119939     DOI： 10.1086/593965

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  7 in total

1.  Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.

Authors:  Anil Pooran; Helen Booth; Robert F Miller; Geoff Scott; Motasim Badri; Jim F Huggett; Graham Rook; Alimuddin Zumla; Keertan Dheda
Journal:  BMC Pulm Med       Date:  2010-02-22       Impact factor: 3.317

2.  Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON®-Gold Testing.

Authors:  Aldo Crossa; Jason Kessler; Tiffany G Harris
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

3.  Delineating a Retesting Zone Using Receiver Operating Characteristic Analysis on Serial QuantiFERON Tuberculosis Test Results in US Healthcare Workers.

Authors:  Wendy Thanassi; Art Noda; Beatriz Hernandez; Jeffery Newell; Paul Terpeluk; David Marder; Jerome A Yesavage
Journal:  Pulm Med       Date:  2012-12-30

4.  Referrals for positive tuberculin tests in new health care workers and students: a retrospective cohort study.

Authors:  Yining Xu; Kevin Schwartzman
Journal:  BMC Public Health       Date:  2010-01-20       Impact factor: 3.295

Review 5.  Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.

Authors:  Anke L Stuurman; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anouk M Oordt-Speets; Andreas Sandgren; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-06-08       Impact factor: 3.090

6.  Change in the Prevalence of Testing for Latent Tuberculosis Infection in the United States: 1999-2012.

Authors:  Nicholas T Vozoris; Jane Batt
Journal:  Can Respir J       Date:  2016-05-30       Impact factor: 2.409

Review 7.  Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist.

Authors:  Swetalina Pradhan; Bhushan Madke; Shekhar Neema; Poonam Kabra; Adarsh Lata Singh; Sangita Yadav
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.